Navigation Links
Cardiome Reports First Quarter Results
Date:5/13/2008

NASDAQ: CRME TSX: COM

VANCOUVER, May 13 /PRNewswire-FirstCall/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today reported financial results for the first quarter ended March 31, 2008. Amounts, unless specified otherwise, are expressed in Canadian dollars and in accordance with Canadian Generally Accepted Accounting Principles (Canadian GAAP). At close of business on March 31, 2008, the exchange rate was CAD$1.00=US$0.9742.

Results of Operations

We recorded a net loss of $22.2 million ($0.35 per common share) for the three months ended March 31, 2008 ("Q1-2008"), compared to a net loss of $14.0 million ($0.23 per common share) for the three months ended March 31, 2007 ("Q1-2007"). The increase in net loss for the current quarter was largely due to lower licensing and research collaborative fees and increased research and development expenditures related to vernakalant (oral) and GED-aPC clinical activities.

Revenue for Q1-2008 was $0.4 million, a decrease of $1.3 million from $1.7 million in Q1-2007. Revenue in Q1-2008 consisted of $0.2 million (Q1-2007 - $0.4 million) in licensing fees and $0.2 million (Q1-2007 - $1.3 million) in research and collaborative fees.

Research and development expenditures were $18.1 million for Q1-2008 compared to $11.8 million for Q1-2007. General and administration expenses decreased to $4.1 million in Q1-2008 from $4.6 million in Q1-2007. Amortization was $1.1 million for Q1-2008 compared to $0.5 million for Q1-2007. Interest and other income was $0.3 million for Q1-2008 compared to $1.4 million for Q1-2007. Foreign exchange gain was $0.3 million for Q1-2008 compared to a loss of $0.2 million in Q1-2007.

Stock-based compensation, a non-cash item included in operating expenses, decreased to $1.0 million for Q1-2008, as compared to $1.5 million for Q1-2007.

Liquidity and Outstanding Share Capital

As of March 31, 2008, the Company had cash and cash
'/>"/>

SOURCE Cardiome Pharma Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Cardiome to Present at Bear Stearns Conference
2. Cardiome to Present at ThinkEquity Conference
3. Cardiome to Present at CIBC Conference
4. Cardiome To Release Third Quarter Results
5. Cardiome Initiates Phase 1 Study for GED-aPC
6. Cardiome Updates Guidance
7. Cardiome to Hold Investor Update Call
8. Cardiome And Astellas Announce Regulatory Update
9. Cardiome Announces Positive Interim Phase 2b Results for Oral Vernakalant and Engages Merrill Lynch as Strategic Advisor
10. Cardiome To Release 2007 Results
11. Cardiome To Release 2008 First Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... As reported by People Magazine in the article ... and Getting Sober (7/15), one of the most popular ... out to the public about his personal transformation. Now, two ... admits that moving on with his life was a challenge. ... drugs in 2012 and even spent some time in rehab. ...
(Date:7/25/2014)... San Diego, CA (PRWEB) July 25, 2014 ... regarding all the latest information from the FDA on ... on July 21, that one lot of Ibuprofen and one ... recalled due to mislabeled packaging. Oxcarbazepine is used ... with epilepsy. , The reason for the recall ...
(Date:7/25/2014)... 25, 2014 Parker Waichman LLP, a ... consumers comments on a recent tobacco lawsuit in which ... $23.6 billion in punitive damages. Cynthia Robinson brought the ... The case is Cynthia Robinson v. R.J. Reynolds Tobacco ... First Circuit Court, Escambia County, Florida; Case Number 2008 ...
(Date:7/25/2014)... 2014 Drexel University College of Medicine ... MS, FACP, has been appointed vice dean for education, effective ... from The Commonwealth Medical College, where she is currently chair ... affairs, and professor of medicine. , As a member ... Weber had a major role in many aspects of the ...
(Date:7/25/2014)... vulnerable neurons and reduce motor deficits in a ... University School of Medicine have shown. , The ... Parkinson,s Disease . , The findings demonstrate that ... at sufficient levels and have beneficial effects when ... Previous studies of XPro1595 in animals tested more ...
Breaking Medicine News(10 mins):Health News:'The Situation' Celebrates 8 Months of Sobriety 2Health News:'The Situation' Celebrates 8 Months of Sobriety 3Health News:Ibuprofen and Oxcarbazepine Tablets Recalled: AttorneyOne Monitors and Keep Consumers Informed 2Health News:A Florida Jury Awards Widow More Than $23 Billion in Punitive Damages in a Lawsuit Brought Against Tobacco Maker, R.J. Reynolds, Parker Waichman LLP Comments 2Health News:A Florida Jury Awards Widow More Than $23 Billion in Punitive Damages in a Lawsuit Brought Against Tobacco Maker, R.J. Reynolds, Parker Waichman LLP Comments 3Health News:Valerie D. Weber, MD, Appointed Vice Dean for Education at Drexel University College of Medicine 2Health News:Valerie D. Weber, MD, Appointed Vice Dean for Education at Drexel University College of Medicine 3Health News:Anti-inflammatory drug can prevent neuron loss in Parkinson's model 2
... PLAINS, N.Y., Oct. 11 "Every Baby Has,a Story," a ... as well as those who need help to survive and ... "This storytelling project lets proud parents all over the country ... said Dr. Jennifer L.,Howse, president of the March of Dimes. ...
... TORONTO, Oct. 10 /PRNewswire/ - CBM President Professor ... for the World Health,Organizations global initiative to eliminate ... the eve of World Sight Day 2007 at ... their longstanding 20 year partnership and,support, both financially ...
... Urges Passage of Plan to Give Access to Affordable ... one week after Cover,All Pennsylvanians, the centerpiece of his ... G. Rendell today held a,town meeting in Erie as ... tour will highlight the need to lower health care ...
... Ganz, President and Chief,Executive Officer of Regence, has been ... health policy experts convened by The Aspen Institute.,The organization ... the,national dialogue on health care reform leading up to ... Stewardship Project will expand the health care debate,to the ...
... who are given drugs in addition to lumpectomies or radiotherapy, ... drugs. This is especially true if their tumors respond to ... published in the online journal, Breast Cancer Research. , "Developing ... terms of survival," explained lead researcher Dr J van der ...
... urges Congress to,pass legislation this year to ... WASHINGTON, Oct. 10 The Health IT ... and former,Representative Nancy Johnson, today applauded Representatives ... that will bring health,information technology to all ...
Cached Medicine News:Health News:'Every Baby Has a Story' Campaign Tours the Nation for March of Dimes 2Health News:World Health Organization thanks CBM For their outstanding work 2Health News:Governor Rendell Launches 'Tour to Insure' In Erie; 2Health News:Governor Rendell Launches 'Tour to Insure' In Erie; 3Health News:Regence CEO to Chair National Effort Promoting Broader Health Care Stewardship 2Health News:Regence CEO to Chair National Effort Promoting Broader Health Care Stewardship 3Health News:Cancer conflict with chemotherapy treatment 2Health News:Health IT Now! Coalition Applauds Representatives Eshoo and Rogers for Introducing Health IT Legislation 2
(Date:7/25/2014)...  CVS Caremark Corporation (NYSE: CVS ) ... 5, 2014, at 8:30 a.m. (EDT) with analysts and ... An audio webcast of the conference call ... of the CVS Caremark website for all interested parties.  ... webcast will be archived and available on the web ...
(Date:7/25/2014)... MARLTON, N.J. , July 25, 2014 /PRNewswire/ ... visibility, brand protection and serialization solutions, has recently ... Business" that addresses current and future needs ... solutions for the old supply chain model no ... advances in technology, including the growth of mobile ...
(Date:7/25/2014)... July 25, 2014 Research and Markets ... Ophthalmic Diagnostic Devices Market 2014-2018" report to their ... About Ophthalmic Diagnostic Device An ... identify a defect or deficiency in the human visual ... disorders such as presbyopia, cataracts, glaucoma, retinal disorders, conjunctivitis, ...
Breaking Medicine Technology:Acsis Addresses Questions on the Modern Supply Chain 2Global Ophthalmic Diagnostic Devices Market 2014-2018: Key Vendors are Alcon, Carl Zeiss, Haag-Streit and Topcon 2
... 9, 2011 Rigel Pharmaceuticals, Inc. (Nasdaq: ... company,s chairman and chief executive officer, is scheduled to ... next week. Details of the events are as follows:Tuesday, ... & Investor ConferencePanel Topic:  "Rheumatoid Arthritis: the Real Joint ...
... YORK, Feb. 9, 2011 Reportlinker.com announces that ... its catalogue: Adalimumab - ... http://www.reportlinker.com/p0366162/Adalimumab---Comprehensive-patent-search.html Eliminate unnecessary risk with ... Pipeline Developer is a regularly updated, professional ...
Cached Medicine Technology:Rigel Announces Participation at Two Investor Conferences 2Reportlinker Adds Adalimumab - Comprehensive Patent Search 2Reportlinker Adds Adalimumab - Comprehensive Patent Search 3Reportlinker Adds Adalimumab - Comprehensive Patent Search 4
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: